April 5, 2012 —Maquet and Siemens Healthcare announced they will collaborate closely to introduce a combined system for diagnostics and surgical procedures. The first systems will be delivered and installed starting May 2012.

April 5, 2012 — The American College of Cardiology (ACC) released a list of “Five Things Physicians and Patients Should Question” in cardiology as part of Choosing Wisely, an initiative of the ABIM Foundation. The list identifies five targeted, evidence-based recommendations that can support physicians in working with their patients to make wise choices about their care.

April 5, 2012 – Siemens Healthcare has announced that the Somatom Definition Flash dual-source computed tomography (CT)
system with the new Stellar Detector – the first fully integrated detector that virtually eliminates electronic noise – has been cleared by the Food and Drug Administration (FDA) for sale and distribution in the United States. The new Stellar Detector further enhances the already outstanding Somatom Definition Flash CT system by delivering high spatial resolution, generating ultra-thin slices and providing an outstanding level of sharpness in CT at impressively low levels of patient radiation. With the combination of the Somatom Definition Flash CT system and the new Stellar Detector, even the finest image details can now be visualized. 

April 5, 2012 - SK Capital Partners, a U.S. based private investment firm, and IBA (Ion Beam Applications S.A.) announced
that they have closed on their previously announced agreement to create IBA Molecular, a jointly-owned company derived from IBA’s worldwide radiopharmaceutical division. IBA Molecular is a worldwide leader in the manufacturing and distribution of radioactive isotopes used for medical imaging and therapy, with over 50 locations in the United States, Europe and Asia and employs over 1,000 people. The transaction is valued at approximately €180 million ($239 million). SK Capital will own 60 percent of the recapitalized entity and IBA will retain a 40 percent stake.

April 5, 2012 - Now, the RadiaGuard line includes Beginning and Advanced Treatment Lotions, Post Treatment Cream, Metallic Free Deodorant and two Moisturizing Lip Relief lip treatments. This scientifically advanced skincare system is specifically designed to counteract the effects of radiation and includes natural ingredients like marigold extract, aloe, jojoba oil and Vitamin E. While RadiaGuard products are reasonably priced as individual products, the new set of all products is value-priced at under $85. Further discounts are available to patients at radiation treatment centers and hospitals. No prescription is required.

A North Carolina practice utilizes Intelerad’s Multi-Method Reporting module and voice recognition platform, IntelePACS and InteleOne to achieve 55 percent productivity gains and 25 percent growth.

Symplicity renal denervation system

April 4, 2012 — Medrad (Bayer) recently introduced the Mark 7 Arterion angiographic contrast injection system. The system is much smaller, lighter-weight, more ergonomic and easier to maneuver than previous Medrad injectors. It also is easier to operate than previous models, requiring less time to position and set up. It has a clearly visible and intuitive user interface to guide the user through proper set-up, and highlights the information need to perform injections.

Increasingly in this country, diagnostic ultrasound is being used to advance a political agenda.  Last month the Virginia state legislature passed, and the governor signed, a law that, effective July 1, requires women seeking an abortion to submit to a fetal ultrasound. In Texas, not only must such an ultrasound be performed, but also the fetus must be described to the patient in terms of its heart rate, its size and the length of its limbs. North Carolina and Oklahoma have laws with similar “speech-and-display” requirements. Four other states are considering such laws. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now